Trial Profile
Clinical Trials Insight: 700051621
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2009
Price :
$35
*
At a glance
- Drugs T 2000 (Primary) ; Propranolol
- Indications Cardiovascular disorders; Epilepsy; Essential tremor; Migraine
- Focus Adverse reactions
- Sponsors Taro Pharmaceutical Industries
- 09 Dec 2009 New trial record.